논문KCI 등재
Letter: Cardiovascular risk of tenofovir disoproxil fumarate or tenofovir alafenamide fumarate in patients with chronic hepatitis B: More questions than an answer – author’s reply
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
참고문헌 (9)
- Hong H, "Cardiovascular risk in chronic hepatitis B patients treated with tenofovir disoproxil fumarate or tenofovir alafenamide", Clin Mol Hepatol, 30, pp.49~63 (2024)
- Cheng PN, "Cardiovascular risk of tenofovir disoproxil fumarate or tenofovir alafenamide in patients with chronic hepatitis B : More questions than an answer", Clin Mol Hepatol, 30, pp.144~146 (2024)
- Agarwal K, "96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection", J Hepatol, 68, pp.672~681 (2018)
- Buti M, "Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection : a randomised, double-blind, phase 3, non-inferiority trial", Lancet Gastroenterol Hepatol, 1, pp.196~206 (2016)
- Lampertico P, "Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patients with chronic hepatitis B : a randomised, double-blind, phase 3, multicentre non-inferiority study", Lancet Gastroenterol Hepatol, 5, pp.441~453 (2020)
- Lim J, "Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate in treatment-naïve chronic hepatitis B", Liver Int, 42, pp.1517~1527 (2022)
- Byun KS, "Tenofovir alafenamide for drug-resistant hepatitis B : A randomized trial for switching from tenofovir disoproxil fumarate", Clin Gastroenterol Hepatol, 20, pp.427~437 (2022)
- Cheng PN, "Body weight increase and metabolic derangements after tenofovir disoproxil fumarate switch to tenofovir alafenamide in patients with chronic hepatitis B", Aliment Pharmacol Ther, 59, pp.230~238 (2024)
- Jeong J, "Tenofovir alafenamide treatment may not worsen the lipid profile of chronic hepatitis B patients : A propensity score-matched analysis", Clin Mol Hepatol, 28, pp.254~264 (2022)
관련 논문AI추천
Reply to correspondence on “Cardiovascular risk in chronic hepatitis B patients treated with tenofovir disoproxil fumarate or tenofovir alafenamide”Ming-Lung Yu, Pin-Nan Cheng대한간학회 · Clinical and Molecular Hepatology2024 · 제30권 제4호Cardiovascular risk of tenofovir disoproxil fumarate or tenofovir alafenamide in patients with chronic hepatitis B: More questions than an answerMing-Lung Yu, Pin-Nan Cheng대한간학회 · Clinical and Molecular Hepatology2024 · 제30권 제2호Correspondence to editorial on “Switching to besifovir in patients with chronic hepatitis B receiving tenofovir disoproxil fumarate: A randomized trial”Hyung Joon Yim, Jin Mo Yang, Seong Hee Kang, Young Kul Jung대한간학회 · Clinical and Molecular Hepatology2026 · 제32권 제1호Dyslipidemia in chronic hepatitis B patients on tenofovir alafenamide: Facts and puzzlesHung-Yao Lin, Tai-Chung Tseng대한간학회 · Clinical and Molecular Hepatology2022 · 제28권 제2호Letter regarding “Hepatitis B core-related antigen dynamics and risk of subsequent clinical relapses after nucleos(t)ide analog cessation”Yun-Fan Liaw대한간학회 · Clinical and Molecular Hepatology2024 · 제30권 제2호Treatment response to nucleos(t)ide analogs in chronic hepatitis B with mildly elevated alanine aminotransferase: Letter to the editor on “Antiviral therapy for chronic hepatitis B with mildly elevated aminotransferase: A rollover study from the TORCH-B trial”Chao Wu, Chuanwu Zhu, Fei Cao, Jian Wang, Rui Huang대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호
이 간행물의 다른 논문 (31건)
Comprehensive approach to controlling chronic hepatitis B in ChinaJidong Jia, Shan Shan, Xinyan Zhaopp. 135-143Cardiovascular risk of tenofovir disoproxil fumarate or tenofovir alafenamide in patients with chronic hepatitis B: More questions than an answerMing-Lung Yu, Pin-Nan Chengpp. 144-146Toward hepatitis C virus elimination using artificial intelligenceJeong-Hoon Lee, Moon Haeng Hurpp. 147-149Starting the journey: Understanding the roles of complement proteins in liver diseases through mendelian randomizationJu Dong Yang, Mohammad Saeid Rezaee-Zavareh, Naomy Kimpp. 150-153Enhancing off-nucleos(t)ide analogue outcome predictions in chronic hepatitis B with time-varying hepatitis B core-related antigenChen-Te Huang, Tai-Chung Tsengpp. 154-156
